Correlation Between Entera Bio and Equillium

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Entera Bio and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entera Bio and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entera Bio and Equillium, you can compare the effects of market volatilities on Entera Bio and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entera Bio with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entera Bio and Equillium.

Diversification Opportunities for Entera Bio and Equillium

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between Entera and Equillium is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Entera Bio and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Entera Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entera Bio are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Entera Bio i.e., Entera Bio and Equillium go up and down completely randomly.

Pair Corralation between Entera Bio and Equillium

Given the investment horizon of 90 days Entera Bio is expected to generate 0.62 times more return on investment than Equillium. However, Entera Bio is 1.6 times less risky than Equillium. It trades about -0.04 of its potential returns per unit of risk. Equillium is currently generating about -0.08 per unit of risk. If you would invest  218.00  in Entera Bio on December 28, 2024 and sell it today you would lose (36.00) from holding Entera Bio or give up 16.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy98.36%
ValuesDaily Returns

Entera Bio  vs.  Equillium

 Performance 
       Timeline  
Entera Bio 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Entera Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Equillium 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Entera Bio and Equillium Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Entera Bio and Equillium

The main advantage of trading using opposite Entera Bio and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entera Bio position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.
The idea behind Entera Bio and Equillium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world